Please login to the form below

Not currently logged in
Email:
Password:

tiragolumab

This page shows the latest tiragolumab news and features for those working in and with pharma, biotech and healthcare.

Roche’s Tecentriq yields positive data in early stage NSCLC

Roche’s Tecentriq yields positive data in early stage NSCLC

In January, Roche also received a breakthrough therapy designation (BTD) from the US Food and Drug Administration (FDA) for a combination of its investigational TIGIT blocker tiragolumab and Tecentriq (atezolizumab) for

Latest news

More from news
Approximately 0 fully matching, plus 2 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

Want to give perfect client service? Tough luck, you’re human
In this article an ex-client of mine, Liz Skrbkova, and I explore the (unhelpful) pressures of trying to perfect the client-agency relationship...
WHITE PAPER: Why do men die younger?
It’s a commonly accepted fact that women outlive men. Wherever you live, there’s a good chance that men will die on average eight years earlier than women. Is this an...
3 tips to show patient diversity in your clinical trial materials
Here are some useful tips to help get your hands on authentically diverse stock photos....

Infographics